Synopsys, Inc. (NASDAQ:SNPS) Stock Has Consensus Price Target of $571.78 According to Analysts

Synopsys, Inc. (NASDAQ:SNPS) has earned a consensus rating of “Moderate Buy” from the twenty-six analysts that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a hold rating, twenty-two have given a buy rating and one has issued a strong buy rating on the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $575.00.

Several equities research analysts have issued reports on SNPS shares. Roth Capital upgraded shares of Synopsys to a “buy” rating in a research note on Friday, September 25th. Wells Fargo & Company upped their price target on shares of Synopsys from $475.00 to $540.00 and gave the stock an “overweight” rating in a research report on Thursday, October 1st. Morgan Stanley raised their price objective on Synopsys from $500.00 to $574.00 and gave the company an “overweight” rating in a research report on Tuesday. Sanford C. Bernstein initiated coverage on Synopsys in a research note on Friday, September 25th. They set an “outperform” rating on the stock. Finally, Weiss Ratings lowered Synopsys from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, September 11th.

Synopsys Stock Performance

NASDAQ:SNPS opened at $422.48 on Tuesday. Synopsys has a fifty-two week low of $362.55 and a fifty-two week high of $539.48. The firm’s 50 day moving average is $430.15 and its two-hundred day moving average is $443.27. The company has a market cap of $80.96 billion, a P/E ratio of 45.85, a P/E/G ratio of 1.84 and a beta of 1.21. The company has a quick ratio of 1.24, a current ratio of 1.34 and a debt-to-equity ratio of 0.29.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, topping the consensus estimate of $3.67 by $0.24. The company had revenue of $2.48 billion during the quarter, compared to analyst estimates of $2.44 billion. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The firm’s revenue was up 42.4% on a year-over-year basis. During the same period in the prior year, the firm posted $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Analysts expect that Synopsys will post 11.00 EPS for the current year.

Synopsys declared that its board has approved a stock repurchase program on Monday, October 5th that authorizes the company to buy back $1.00 billion in shares. This buyback authorization authorizes the semiconductor company to purchase up to 1.1% of its stock through open market purchases. Share buyback programs are generally an indication that the company’s board of directors believes its stock is undervalued.

Insider Buying and Selling

In other Synopsys news, insider Aart de Geus sold 25,000 shares of the business’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $441.76, for a total value of $11,044,000.00. Following the transaction, the insider owned 120,421 shares in the company, valued at $53,197,180.96. The trade was a 17.19% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Janet Lee sold 1,144 shares of the business’s stock in a transaction on Tuesday, October 6th. The stock was sold at an average price of $502.52, for a total transaction of $574,882.88. Following the completion of the transaction, the insider owned 16,534 shares in the company, valued at $8,308,665.68. This represents a 6.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 117,163 shares of company stock worth $51,366,457 in the last 90 days. 0.56% of the stock is owned by insiders.

Institutional Investors Weigh In On Synopsys

A number of hedge funds have recently bought and sold shares of SNPS. Sankala Group LLC acquired a new stake in shares of Synopsys during the fourth quarter worth approximately $25,000. Elevation Wealth Partners LLC raised its holdings in Synopsys by 96.4% in the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock valued at $25,000 after acquiring an additional 27 shares in the last quarter. Osbon Capital Management LLC bought a new position in Synopsys during the 2nd quarter valued at $25,000. IMG Wealth Management Inc. bought a new position in Synopsys during the 2nd quarter valued at $28,000. Finally, GK Wealth Management LLC acquired a new position in Synopsys during the 3rd quarter worth $28,000. Institutional investors and hedge funds own 85.47% of the company’s stock.

About Synopsys

Synopsys, Inc is an electronic design automation (EDA) and semiconductor intellectual property company serving the global semiconductor and electronics industries. Its software helps engineers design, verify, test and manufacture advanced integrated circuits and electronic systems.

The company’s products and services support digital and analog design, functional verification, design-for-test, manufacturing and semiconductor engineering workflows. Synopsys also provides reusable semiconductor IP, including processor cores, interface technologies, security solutions and other components used in system-on-chip designs.

In addition to its semiconductor design offerings, Synopsys provides software development and application security tools intended to help organizations identify and manage vulnerabilities and risks across the software development lifecycle.